News

Researchers have developed a smart device for personalized skin care modeled after the male diving beetle. The device collects and monitors body fluids while sticking to the skin, paving the way for more accurate diagnostics and treatments for skin diseases.

Each tumor consists of multiple cell types, and in addition to determining the course of the disease, differences between individual cancer cells control the effectiveness of targeted therapies. A team of researchers has been able to see the way in which cancer cells sometimes develop resistance following treatment.

A large-scale, long-term trial that investigated a new strategy using a combination of very low doses of four medicines in one capsule, has shown significantly improved control of high blood pressure.

Researchers have uncovered a weakness in a key enzyme that solid tumor cancer cells rely on to adapt and survive when oxygen levels are low.

Scientists have developed a set of compounds that target estrogen-sensitive breast cancer cells in new ways, potentially creating better options for patients with treatment-resistant cancers.

Researchers have identified three new urinary biomarkers that could be used to detect consumption of ADB-BUTINACA, an emerging synthetic cannabinoid which is a type of new psychoactive substance. The tests could help to boost surveillance of designer drug abuse.

A team of MIT engineers, in collaboration with scientists from Brigham and Women’s Hospital and Novo Nordisk, is working on an alternative delivery strategy that could make it much easier for patients to benefit from monoclonal antibodies and other drugs that usually have to be injected.

Looking in detail at patient vaccine response within disease subgroups, researchers found that a significant proportion of patients studied as part of the OCTAVE trial generate lower levels of SARS-CoV-2 antibody reactivity, when compared with healthy subjects after two SARS-CoV-2 vaccines.

Researchers have discovered a treatment for canine glioblastoma – the second-most common type of brain cancer in dogs – that reduced the volume of some dogs’ tumors. The findings have promising implications for the human version of the aggressive brain cancer.

The inexpensive oral antidepressant fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30%, according to a study.